In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model.
about
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatusPremedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia.
P2860
In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vivo efficacy of a new quin ...... s pneumoniae in a mouse model.
@en
type
label
In vivo efficacy of a new quin ...... s pneumoniae in a mouse model.
@en
prefLabel
In vivo efficacy of a new quin ...... s pneumoniae in a mouse model.
@en
P2093
P2860
P1476
In vivo efficacy of a new quin ...... s pneumoniae in a mouse model.
@en
P2093
Ikuo Murata
Jun-ichi Kadota
Katsunori Yanagihara
Kazuhiro Tsukamoto
Kazunori Tomono
Shigeru Kohno
Takayoshi Tashiro
Yoichi Hirakata
Yoshiko Otsu
Yoshitsugu Miyazaki
P2860
P304
P356
10.1128/AAC.47.12.3699-3703.2003
P407
P577
2003-12-01T00:00:00Z